HopeStage
Back to all studies
Active Not RecruitingNCT02734602

Brain synapse imaging in depression and PTSD, with ketamine scans

About this titleRead the official source — NCT02734602
Medication studyAges 18–70United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2016
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
130
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT02734602
Official title
Show the full official title

Imaging SV2A in Mood Disorders

Recruitment & locations

Not recruiting

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including ketamine.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies